Great Tree Pharmacy Co., Ltd. (6469.TWO)
TWD 151.0
(-1.63%)
TWD 151.0
(-1.63%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 1.6 Billion TWD | 4.24% |
| 2022 | 1.53 Billion TWD | 47.09% |
| 2021 | 1.04 Billion TWD | 48.41% |
| 2020 | 703.26 Million TWD | 33.18% |
| 2019 | 528.03 Million TWD | 156.37% |
| 2018 | 205.96 Million TWD | 20.01% |
| 2017 | 171.61 Million TWD | 14.98% |
| 2016 | 149.25 Million TWD | 17.57% |
| 2015 | 126.95 Million TWD | -8.54% |
| 2014 | 138.78 Million TWD | 44.37% |
| 2013 | 96.13 Million TWD | 128.92% |
| 2012 | 50.67 Million TWD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | 426 Million TWD | 0.76% |
| 2024 Q1 | 422.95 Million TWD | -1.22% |
| 2023 Q4 | 428.19 Million TWD | 8.12% |
| 2023 Q1 | 377.57 Million TWD | -3.05% |
| 2023 Q3 | 396.02 Million TWD | -0.65% |
| 2023 Q2 | 398.62 Million TWD | 5.58% |
| 2023 FY | - TWD | 4.24% |
| 2022 Q1 | 300.11 Million TWD | 5.68% |
| 2022 FY | - TWD | 47.09% |
| 2022 Q4 | 389.46 Million TWD | 2.23% |
| 2022 Q3 | 380.97 Million TWD | -18.02% |
| 2022 Q2 | 464.71 Million TWD | 54.85% |
| 2021 Q3 | 269.36 Million TWD | -2.08% |
| 2021 Q1 | 215.38 Million TWD | 8.81% |
| 2021 FY | - TWD | 48.41% |
| 2021 Q4 | 283.98 Million TWD | 5.43% |
| 2021 Q2 | 275.08 Million TWD | 27.72% |
| 2020 FY | - TWD | 33.18% |
| 2020 Q3 | 175.9 Million TWD | 6.11% |
| 2020 Q2 | 165.77 Million TWD | 1.31% |
| 2020 Q1 | 163.63 Million TWD | 9.31% |
| 2020 Q4 | 197.94 Million TWD | 12.53% |
| 2019 Q3 | 138.82 Million TWD | 6.55% |
| 2019 Q4 | 149.7 Million TWD | 7.84% |
| 2019 FY | - TWD | 156.37% |
| 2019 Q1 | 109.21 Million TWD | 69.76% |
| 2019 Q2 | 130.29 Million TWD | 19.3% |
| 2018 Q3 | 53.65 Million TWD | 18.42% |
| 2018 Q2 | 45.31 Million TWD | 6.21% |
| 2018 FY | - TWD | 20.01% |
| 2018 Q1 | 42.66 Million TWD | -37.9% |
| 2018 Q4 | 64.33 Million TWD | 19.89% |
| 2017 Q1 | 29.82 Million TWD | -29.1% |
| 2017 FY | - TWD | 14.98% |
| 2017 Q3 | 40.88 Million TWD | 26.93% |
| 2017 Q4 | 68.7 Million TWD | 68.07% |
| 2017 Q2 | 32.2 Million TWD | 7.98% |
| 2016 Q4 | 42.06 Million TWD | 1.82% |
| 2016 FY | - TWD | 17.57% |
| 2016 Q3 | 41.31 Million TWD | 26.2% |
| 2016 Q2 | 32.73 Million TWD | 42.85% |
| 2016 Q1 | 22.91 Million TWD | -55.21% |
| 2015 Q2 | 31.23 Million TWD | 510.0% |
| 2015 FY | - TWD | -8.54% |
| 2015 Q4 | 51.17 Million TWD | 66.33% |
| 2015 Q3 | 30.76 Million TWD | -1.52% |
| 2015 Q1 | 5.12 Million TWD | -90.8% |
| 2014 Q3 | 24.04 Million TWD | -1.16% |
| 2014 Q4 | 55.68 Million TWD | 131.65% |
| 2014 Q2 | 24.32 Million TWD | 0.0% |
| 2014 Q1 | 24.32 Million TWD | 5.78% |
| 2014 FY | - TWD | 44.37% |
| 2013 FY | - TWD | 128.92% |
| 2013 Q4 | 22.99 Million TWD | 0.0% |
| 2013 Q3 | 22.99 Million TWD | 27.93% |
| 2013 Q1 | 17.97 Million TWD | 0.0% |
| 2013 Q2 | 17.97 Million TWD | 0.0% |
| 2012 FY | - TWD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|